Structure-guided design of a truncated heterobivalent chemical probe degrader of IRE1α

Breanna L. Zerfas, Yingpeng Liu, Jianwei Che, Katherine A. Donovan, John M. Hatcher, Fidel Huerta, Rebecca J. Metivier, Radosław P. Nowak, Leah Ragosta, Tiffany Tsang, Eric S. Fischer and Lyn H. Jones

RSC Med. Chem., 2025, 16, 2460
DOI: 10.1039/D5MD00028A

Effect of mitochondrial translocator protein TSPO on LPS-induced cardiac dysfunction

Xingyue Li, Xiao Chen, Feng-yuan Yang, Tingting Shu, Lintao Jiang, Bo He, Ming Tang, Xingbing Li, Dandong Fang, Pedro A. Jose, Yu Han, Yongjian Yang and Chunyu Zeng

Journal of Advanced Research, 2025, 74, 455
DOI: 10.1016/j.jare.2024.10.004

Design, synthesis, and biological evaluation of novel BTK-targeting proteolysis targeting chimeras (PROTACs) with enhanced pharmacokinetic properties

Ying Lin, Jing Liu, Xinjian Tian, Jin Wang, Huahua Su, Jianpin Xiang, Tao Cao, Yonghui Wang, Qiong Xie and Xufen Yu

European Journal of Medicinal Chemistry, 2025, 289, 117420
DOI: 10.1016/j.ejmech.2025.117420

FDA-approved kinase inhibitors in PROTAC design, development and synthesis

Kacper Kossakowski, Alina Cherniienko, Lucjusz Zaprutko and Anna Pawełczyk

Journal of Enzyme Inhibition and Medicinal Chemistry, 2025, 40
DOI: 10.1080/14756366.2025.2542357

Characteristic roadmap of linker governs the rational design of PROTACs

Yawen Dong, Tingting Ma, Ting Xu, Zhangyan Feng, Yonggui Li, Lingling Song, Xiaojun Yao, Charles R. Ashby and Ge-Fei Hao

Acta Pharmaceutica Sinica B, 2024, 14, 4266
DOI: 10.1016/j.apsb.2024.04.007

PROTAC delivery in tumor immunotherapy: Where are we and where are we going?

Yiyang Li, Yike Wu, Sihan Gao, Tao Sun and Chen Jiang

Journal of Controlled Release, 2025, 378, 116
DOI: 10.1016/j.jconrel.2024.11.076

Acrylamide Bioisosterism: Alkenyl Aromatic Heterocycles as Reactivity-Tunable Warheads for Covalent BTK Inhibitors

Yang Li, Siyu Fu, Jun Yang, Wentao Tang, Jifa Zhang, Wuyu Mao and Liang Ouyang

J. Med. Chem., 2026, 69, 5828
DOI: 10.1021/acs.jmedchem.5c03212

Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms

Samir Mouhssine, Nawar Maher, Bassam Francis Matti, Alaa Fadhil Alwan and Gianluca Gaidano

IJMS, 2024, 25, 3234
DOI: 10.3390/ijms25063234

Pharmacokinetic Studies of a Novel c‐Met Targeting PROTAC Drug Candidate Using UPLC‐MS/MS Quantification Methods

Yan Gao, Xinyu Li, Chao Xin, Xiangdong Su, Lianfeng Ai, Jiangmeng Zeng, Shilin Liu and Jinxu Wang

Biopharm & Drug Disp, 2026, 47, 37
DOI: 10.1002/bdd.70022